ARTICLE | Company News
Corgenix Medical Corp., Genesis Bioventures deal
July 1, 2002 7:00 AM UTC
The companies partnered to develop an Elisa-based breast cancer screening diagnostics using GBI's Mammastatin Serum Assay (MSA). CONX will use its Elisa technology to develop the products. ...